MET-GGGo

N/A

Report date: 2026/04/08 20:02:35

NME

Base Information

Drug NameMET-GGGo

Drug Alias NameMET-GGGo

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon receptor agonists

TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesD&D Pharmatech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsObesity

Inactive IndicationsN/A

ATC CodeN/A